1. Home
  2. REG vs GH Comparison

REG vs GH Comparison

Compare REG & GH Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Regency Centers Corporation

REG

Regency Centers Corporation

HOLD

Current Price

$77.89

Market Cap

14.2B

Sector

Real Estate

ML Signal

HOLD

Logo Guardant Health Inc.

GH

Guardant Health Inc.

HOLD

Current Price

$86.76

Market Cap

13.3B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
REG
GH
Founded
1963
2011
Country
United States
United States
Employees
507
N/A
Industry
Real Estate Investment Trusts
Medical Specialities
Sector
Real Estate
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
14.2B
13.3B
IPO Year
N/A
2018

Fundamental Metrics

Financial Performance
Metric
REG
GH
Price
$77.89
$86.76
Analyst Decision
Buy
Strong Buy
Analyst Count
15
19
Target Price
$80.07
$119.79
AVG Volume (30 Days)
1.2M
2.0M
Earning Date
04-29-2026
05-07-2026
Dividend Yield
3.80%
N/A
EPS Growth
N/A
6.74
EPS
N/A
N/A
Revenue
N/A
$982,021,000.00
Revenue This Year
$3.04
$33.30
Revenue Next Year
$4.52
$28.27
P/E Ratio
$26.85
N/A
Revenue Growth
N/A
32.88
52 Week Low
$66.86
$36.36
52 Week High
$81.66
$120.74

Technical Indicators

Market Signals
Indicator
REG
GH
Relative Strength Index (RSI) 45.25 46.59
Support Level $69.71 $82.33
Resistance Level $79.90 $98.58
Average True Range (ATR) 1.25 4.64
MACD -0.20 -0.12
Stochastic Oscillator 7.08 44.51

Price Performance

Historical Comparison
REG
GH

About REG Regency Centers Corporation

Regency Centers is one of the largest shopping center-focused retail REITs. The company's portfolio includes an interest in 481 properties, which includes over 58 million square feet of retail space following the completion of the Urstadt Biddle acquisition in August 2023. The portfolio is geographically diversified with 22 regional offices and no single market representing more than 12% of total company net operating income. Regency's retail portfolio is primarily composed of grocery-anchored centers, with 80% of properties featuring a grocery anchor and grocery stores representing 20% of annual base rent.

About GH Guardant Health Inc.

Guardant Health, based in Redwood City, California, is a leader in liquid-based cancer tests for clinical and research use. The company offers Guardant360 LDT, a liquid biopsy test for treatment selection in advanced-stage cancer, Guardant360 CDx, an FDA-approved companion diagnostic for several targeted therapies, and Guardant Omni, a broader gene panel for immuno-oncology research. In 2021, Guardant launched Reveal, a tumor-agnostic molecular residual disease test. In 2024, the company received US FDA approval for Shield, a liquid biopsy for colorectal cancer screening. Additionally, Guardant offers research development services such as regulatory approval consultancy and clinical trial referrals.

Share on Social Networks: